查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1587834

合成生物學市場規模、佔有率、趨勢分析報告：2025-2030 年按產品、技術、應用、最終用途、地區和細分市場進行的預測

Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits), By Technology (PCR, NGS), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

合成生物學市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球合成生物學市場規模將達到420.6億美元，2025年至2030年複合年成長率為17.30%。

支持疫苗研究的政府和私人資金的存在以及臨床試驗中強大的產品平臺是市場的關鍵驅動力。合成生物製程在生產用於疾病鑑定的抗原和診斷劑、加速疫苗開發以及提高疫苗的整體性能和產量方面具有決定性的優勢。

此外，政府機構的支持和多個項目的存在正在推動市場成長。例如，在美國，COVID-19 疫苗的研發、製造、監管和採購由聯邦機構負責，包括生物醫學高級研究與開發局 (BARDA)、國立衛生研究院 (NIH)、國防部、 FDA 等（先前的OWS）得到機構合作的大力支持。

紡織和營養等行業需求的增加等其他因素也促進了市場的成長。在合成生物學的幫助下，已經確定了幾種最佳的食品生產流程。此外，合成生物學預計將有助於提高農業產量並發展害蟲防治。預計它將有助於提高食品產量和害蟲防治管理。

COVID-19 大流行預計將對市場成長產生積極影響。美國衛生研究院稱讚合成生物學是加速疫苗開發的方法。因此，合成生物學實驗室和公司正在積極利用這項技術來對抗 COVID-19 大流行。因此，在大流行期間，這些技術的使用預計會增加。

對個人化醫療的需求不斷成長預計將成為未來幾年市場成長的主要動力。設計用作治療劑的新型蛋白質的使用例證了醫學領域的合成生物學。這些蛋白質的設計對蛋白質結構進行了一些修改，以獲得治療所需的所需特性。例如，研究人員正在開發在胃腸道中穩定且可口服治療苯酮尿症 (PKU) 的候選治療酶。

另一方面，合成生物學引起了有關生物安保和生物安全的一些擔憂。接觸這些產品可能會對公共衛生和環境造成未知的風險。為了防止此類問題，歐洲、美洲和亞洲國家正在製定政策來管理合成生物學技術在基礎和應用研究中的應用。

合成生物市場報告亮點

  • 從技術角度來看，PCR領域佔據了最大的市場佔有率。這是因為現代生命科學正在加速發展，PCR技術在醫學研究、病毒檢測、食品飲料產業等許多領域中廣泛應用。
  • 預計基因組編輯領域將在預測期內穩定成長。這使得研究人員能夠修改多種生物的 DNA，包括植物、細菌和動物，預計未來幾年對其的需求將會激增。
  • 以產品來看，寡核苷酸和合成 DNA 的市場佔有率預計將在 2030 年增加。合成價格的下降以及對許多應用中使用的合成 DNA、RNA 和基因的需求不斷增加，推動了這一領域的成長。
  • 從應用來看，醫療保健領域在全球市場中佔有很大佔有率。這是由於藥物篩檢和藥物發現的增加。此外，合成生物學的使用降低了藥物發現成本並促進了市場成長。
  • 按最終用途分類，到 2024 年，生物技術和製藥公司產業將佔據主要佔有率。這是由於現代研究設施的不斷增加、有利的立法以及政府的援助和資助。
  • 由於該地區研發投資高、技術先進的醫療保健研究框架的可用性以及合成生物學市場的開拓，北美將在 2024 年被定位為主導市場。
  • 由於個人化治療的興起和主要企業的存在，預計亞太地區在未來幾年將出現可觀的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢及展望
  • 市場動態
    • 擴大合成生物學的應用
    • 政府和私人組織增加資金和支持
    • 擴大合成生物學的研發活動
  • 市場限制因素分析
    • 生物安全和生物安保問題
    • 道德問題和意外後果
  • 產業分析工具
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
    • COVID-19 影響分析

第4章 產品經營分析

  • 產品細分儀表板
  • 全球合成生物市場：產品變異分析
  • 2018-2030年全球合成生物學市場規模及趨勢分析（依產品）
  • 寡核苷酸/寡核苷酸叢集和合成 DNA
    • 寡核苷酸/寡核苷酸叢集和合成 DNA 市場，2018-2030
  • 酵素
    • 酵素市場，2018-2030
  • 克隆技術套件
    • 克隆技術套件市場，2018-2030
  • 異源核酸
    • 異源核酸市場，2018-2030
  • 底盤有機體
    • 底盤機體市場，2018-2030

第5章技術商業分析

  • 技術細分儀表板
  • 全球合成生物學市場：技術波動分析
  • 2018-2030 年全球合成生物學市場規模與趨勢分析（按技術）
  • PCR
    • PCR市場，2018-2030
  • 基因組編輯
    • 基因組編輯市場，2018-2030
  • NGS
    • NGS 市場，2018-2030
  • 生物加工技術
    • 生物製程技術市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第 6 章應用程式的商業分析

  • 使用細分儀表板
  • 全球合成生物學市場：應用變遷分析
  • 2018-2030 年全球合成生物學市場規模與趨勢分析（按應用）
  • 合成生物市場：技術變遷分析
  • 衛生保健
    • 醫療保健市場，2018-2030
    • 臨床
    • 非臨床
  • 非醫療保健
    • 非醫療保健市場，2018-2030
    • 生物技術作物
    • 特種化學品
    • 生質燃料
    • 其他

第 7 章最終用途業務分析

  • 最終用途細分儀表板
  • 全球合成生物學市場：最終用途變化分析
  • 2018-2030 年全球合成生物學市場規模與趨勢分析（依最終用途）
  • 生物技術和製藥公司
    • 生物技術和製藥公司市場，2018-2030
  • 學術研究所
    • 學術研究機構市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第8章區域業務分析

  • 區域儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
    • 北美合成生物市場，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲合成生物學市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太合成生物市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲合成生物市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲合成生物學市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 參與企業
  • 策略規劃
  • 2024 年企業市場分析
  • 參與企業概況
    • Bota Biosciences Inc.
    • Codexis, Inc.
    • Creative Biogene
    • Creative Enzymes
    • Enbiotix, Inc.
    • Illumina, Inc.
    • Merck KGaA
    • New England Biolabs
    • Eurofins Scientific
    • Novozymes
    • Pareto Bio, Inc.
    • Scarab Genomics, Inc.
    • Synthego
    • Synthetic Genomics Inc.
    • Thermo Fisher Scientific, Inc.
Product Code: 978-1-68038-182-5

Synthetic Biology Market Growth & Trends:

The global synthetic biology market size is expected to reach USD 42.06 billion by 2030, registering a CAGR of 17.30% 2025 to 2030, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market. Synthetic biology processes provide crucial advantages for producing antigen and diagnostic reagents for disease identification, accelerating the speed of vaccine development, and improving overall vaccine performance and yield.

Furthermore, support from government agencies and the presence of several programs are likely to boost the market growth. For instance, in the U.S., COVID-19 vaccine R&D, manufacture, regulation, and purchase have been highly supported by collaboration between federal agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), DOD, FDA, and others (formerly OWS).

Other factors such as expanding demand in industries such as textiles and nutrition are also contributing to the market growth. Several optimal food production processes have been identified with the help of synthetic biology. In addition, synthetic biology is predicted to aid in the generation of higher agricultural yields and pest control development. It is expected to help in the production of better food yield and pest control management.

The COVID-19 pandemic is anticipated to positively impact market growth. Synthetic biology has been highlighted as a means to accelerate vaccine development by the National Institute of Health in the U.S. Therefore, synthetic biology labs and companies have been actively utilizing this technology to combat the COVID-19 pandemic. As a result, the usage of these technologies is projected to increase during the outbreak.

The growing demand for personalized medicine is expected to majorly drive market growth during the coming years. The use of engineered novel proteins for use as therapeutics has demonstrated synthetic biology in the medical segment. These proteins are designed with some modified protein structure to get the desirable properties required for the treatment. For instance, researchers are developing a therapeutic enzyme candidate that is GI-stable and can be given via oral route to treat Phenylketonuria (PKU).

On the other hand, synthetic biology has raised a few concerns regarding biosecurity and biosafety. Exposure to these products may cause unknown hazards to public health and the environment. To prevent such issues, countries of Europe, the Americas, and Asia have formulated policies to manage the application of synthetic biology techniques in basic & applied research.

Synthetic Biology Market Report Highlights:

  • By technology, the PCR segment held the largest share of the market. This is attributed to the accelerated development in modern life science, with PCR technology being widely employed in numerous fields of medical research, virus detection, and the food & beverage industry
  • The genome-editing segment is expected to grow steadily during the forecast period. It enables researchers to modify the DNA of various organisms, including plants, bacteria, and animals, and their demand is expected to skyrocket in the coming years
  • By product, Oligonucleotide and Synthetic DNA is anticipated to have the larger market share in 2030. The falling price of synthesis and increasing requirement for synthetic DNA, RNA, and genes that are employed in numerous applications contribute to the segment growth
  • By application, the healthcare segment held a larger global market share. This is attributed to an increase in drug screening and discovery. Moreover, the use of synthetic biology can reduce the cost of drug discovery and propel market growth
  • By end-user, the biotechnology and pharmaceutical companies segment held a larger share in 2024, owing to the growing availability of modern research facilities, favorable legislation, and government assistance and funding
  • North America was positioned as the dominant market in 2024 due to the presence of high R&D investment, the availability of technologically advanced healthcare research frameworks, and the development of the synthetic biology market in the region
  • The Asia Pacific is expected to witness considerable growth in the future owing to the rising development of personalized treatment and the presence of key players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing Applications of Synthetic Biology
    • 3.3.2. Growing Funding and Assistance from Government and Private Organization
    • 3.3.3. Growing Research and Development Activities in Synthetic Biology
  • 3.4. Market Restraint Analysis
    • 3.4.1. Biosafety and Biosecurity Issue
    • 3.4.2. Ethical Issues and Unintended Consequences
  • 3.5. Industry Analysis Tools
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Synthetic Biology Market: Product Movement Analysis
  • 4.3. Global Synthetic Biology Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Oligonucleotide/Oligo pools and Synthetic DNA
    • 4.4.1. Oligonucleotide/Oligo pools and Synthetic DNA Market, 2018 - 2030 (USD Million)
  • 4.5. Enzymes
    • 4.5.1. Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6. Cloning Technologies Kits
    • 4.6.1. Cloning Technologies Kits Market, 2018 - 2030 (USD Million)
  • 4.7. Xeno-nucleic Acids
    • 4.7.1. Xeno-nucleic Acids Market, 2018 - 2030 (USD Million)
  • 4.8. Chassis Organism
    • 4.8.1. Chassis Organism Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Global Synthetic Biology Market: Technology Movement Analysis
  • 5.3. Global Synthetic Biology Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. PCR
    • 5.4.1. PCR Market, 2018 - 2030 (USD Million)
  • 5.5. Genome Editing
    • 5.5.1. Genome Editing Market, 2018 - 2030 (USD Million)
  • 5.6. NGS
    • 5.6.1. NGS Market, 2018 - 2030 (USD Million)
  • 5.7. Bioprocessing Technology
    • 5.7.1. Bioprocessing Technology Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Synthetic Biology Market: Application Movement Analysis
  • 6.3. Global Synthetic Biology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Synthetic Biology Market: Technology Movement Analysis
  • 6.5. Healthcare
    • 6.5.1. Healthcare Market, 2018 - 2030 (USD Million)
    • 6.5.2. Clinical
      • 6.5.2.1. Clinical Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Bio/Pharmaceuticals
        • 6.5.2.2.1. Bio/Pharmaceuticals Market, 2018 - 2030 (USD Million)
      • 6.5.2.3. Diagnostics
        • 6.5.2.3.1. Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.5.3. Non-Clinical
      • 6.5.3.1. Non-Clinical Market, 2018 - 2030 (USD Million)
  • 6.6. Non-Healthcare
    • 6.6.1. Non-Healthcare Market, 2018 - 2030 (USD Million)
    • 6.6.2. Biotech Crops
      • 6.6.2.1. Biotech Crops Market, 2018 - 2030 (USD Million)
    • 6.6.3. Specialty Chemicals
      • 6.6.3.1. Specialty Chemicals Market, 2018 - 2030 (USD Million)
    • 6.6.4. Bio-Fuels
      • 6.6.4.1. Bio-Fuels Market, 2018 - 2030 (USD Million)
    • 6.6.5. Others
      • 6.6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Synthetic Biology Market: End Use Movement Analysis
  • 7.3. Global Synthetic Biology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Biotechnology and Pharmaceutical Companies
    • 7.4.1. Biotechnology and Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. U.S. Synthetic Biology Market, 2018 - 2030 (USD MILLION)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Canada Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Mexico Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Germany Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. UK Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. France Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Italy Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Spain Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Denmark Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Sweden Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Target Disease Prevalence
      • 8.4.9.3. Competitive Scenario
      • 8.4.9.4. Regulatory Framework
      • 8.4.9.5. Norway Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Japan Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. China Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. India Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. South Korea Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Regulatory Framework
      • 8.5.6.5. Australia Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Regulatory Framework
      • 8.5.7.5. Thailand Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Brazil Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Argentina Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Regulatory Framework
      • 8.7.2.5. South Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Regulatory Framework
      • 8.7.3.5. Saudi Arabia Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Target Disease Prevalence
      • 8.7.4.3. Competitive Scenario
      • 8.7.4.4. Regulatory Framework
      • 8.7.4.5. UAE Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Target Disease Prevalence
      • 8.7.5.3. Competitive Scenario
      • 8.7.5.4. Regulatory Framework
      • 8.7.5.5. Kuwait Synthetic Biology Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Participant's Overview
    • 9.4.1. Bota Biosciences Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Codexis, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Creative Biogene
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Creative Enzymes
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Enbiotix, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Illumina, Inc.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Merck KGaA
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. New England Biolabs
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Eurofins Scientific
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Novozymes
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Pareto Bio, Inc.
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Scarab Genomics, Inc.
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. Synthego
      • 9.4.13.1. Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Synthetic Genomics Inc.
      • 9.4.14.1. Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Thermo Fisher Scientific, Inc.
      • 9.4.15.1. Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Synthetic Biology Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 11 North America Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 North America Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Mexico Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Mexico Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Europe Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Europe Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Europe Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Germany Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 34 UK Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 UK Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 36 UK Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 UK Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 38 France Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 France Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 France Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 France Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Italy Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Italy Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Italy Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48 Spain Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 Spain Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 52 Denmark Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Denmark Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 Sweden Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 57 Sweden Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Norway Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 Norway Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Norway Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 67 China Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 China Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 China Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 China Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 71 Japan Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Japan Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Japan Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 75 India Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 India Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 77 India Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 India Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 79 South Korea Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 81 South Korea Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 82 South Korea Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 83 Australia Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Australia Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 Australia Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Thailand Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Thailand Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Latin America Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 Latin America Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Latin America Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Brazil Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 Brazil Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 99 Brazil Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 102 Argentina Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 111 South Africa Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 119 UAE Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 120 UAE Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Synthetic Biology Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Synthetic Biology Market: Product Key Takeaways
  • Fig. 14 Global Synthetic Biology Market: Product Movement Analysis
  • Fig. 15 Global Synthetic Biology Market, for Oligonucleotide/Oligo pools and Synthetic DNA, 2018 - 2030 (USD Million)
  • Fig. 16 Global Synthetic Biology Market, for Enzymes, 2018 - 2030 (USD Million)
  • Fig. 17 Global Synthetic Biology Market, for Cloning Technologies Kits, 2018 - 2030 (USD Million)
  • Fig. 18 Global Synthetic Biology Market, for Xeno-nucleic acids, 2018 - 2030 (USD Million)
  • Fig. 19 Global Synthetic Biology Market, for Chassis Organism, 2018 - 2030 (USD Million)
  • Fig. 20 Global Synthetic Biology Market: Technology Key Takeaways
  • Fig. 21 Global Synthetic Biology Market: Technology Movement Analysis
  • Fig. 22 Global Synthetic Biology Market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 23 Global Synthetic Biology Market, for Genome Editing, 2018 - 2030 (USD Million)
  • Fig. 24 Global Synthetic Biology Market, for NGS, 2018 - 2030 (USD Million)
  • Fig. 25 Global Synthetic Biology Market, for Bioprocessing Technology, 2018 - 2030 (USD Million)
  • Fig. 26 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Synthetic Biology Market: Application Key Takeaways
  • Fig. 28 Global Synthetic Biology Market, Application Movement Analysis
  • Fig. 29 Global Synthetic Biology Market, for Healthcare, 2018 - 2030 (USD Million)
  • Fig. 30 Global Synthetic Biology Market, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 31 Global Synthetic Biology Market, for Bio/Pharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 32 Global Synthetic Biology Market, for Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 33 Global Synthetic Biology Market, for Non-Clinical, 2018 - 2030 (USD Million)
  • Fig. 34 Global Synthetic Biology Market, for Non-Healthcare, 2018 - 2030 (USD Million)
  • Fig. 35 Global Synthetic Biology Market, for Biotech Crops, 2018 - 2030 (USD Million)
  • Fig. 36 Global Synthetic Biology Market, for Specialty Chemiclas, 2018 - 2030 (USD Million)
  • Fig. 37 Global Synthetic Biology Market, for Bio-fuels, 2018 - 2030 (USD Million)
  • Fig. 38 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 39 Global Synthetic Biology Market: End Use Movement Analysis
  • Fig. 40 Global Synthetic Biology Market, for Biotechnology and Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 41 Global Synthetic Biology Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 42 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 43 Regional Marketplace: Key Takeaways
  • Fig. 44 Regional Outlook, 2024 & 2030
  • Fig. 45 North America Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 51 UK Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 52 France Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 53 Italy Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 54 Spain Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 60 China Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 61 India Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait Synthetic Biology Market, 2018 - 2030 (USD Million)